Reye's syndrome and salicylate use - PubMed (original) (raw)
- PMID: 7454476
Reye's syndrome and salicylate use
K M Starko et al. Pediatrics. 1980 Dec.
Abstract
During an outbreak of influenza A, seven patients with Reye's syndrome and 16 ill classmate control subjects were evaluated for characteristics of the patients' prodromal illness and the control subjects illness and for medication usage. Patients during the prodrome and control subjects had similar rates of sore throat, coryza, cough, headache, and gastrointestinal complaints except for documented fever which occurred significantly more often in patients than in control subjects (P = .05). While medications which did not contain salicylate were taken as frequently by patients as control subjects, patients took more salicylate-containing medications than did control children (P < .01). All seven patients took salicylate whereas only eight of 16 control subjects did so (P < .05). Patients took larger doses of salicylate than did the entire control group (P < .01). When the eight control subjects who took salicylate were compared with the patients, the patients still tended to take larger doses (P = .08). Patients with fever took salicylate more frequently than control subjects with fever (P < .01). In addition, salicylate consumption was correlated with severity of Reye's syndrome (P < .05). It is postulated that salicylate, operating in a dose-dependent manner, possibly potentiated by fever, represents a primary causative agent of Reye's syndrome.
Similar articles
- Public Health Service study of Reye's syndrome and medications. Report of the main study.
Hurwitz ES, Barrett MJ, Bregman D, Gunn WJ, Pinsky P, Schonberger LB, Drage JS, Kaslow RA, Burlington DB, Quinnan GV, et al. Hurwitz ES, et al. JAMA. 1987 Apr 10;257(14):1905-11. JAMA. 1987. PMID: 3820509 - Reye's syndrome in the United States from 1981 through 1997.
Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Belay ED, et al. N Engl J Med. 1999 May 6;340(18):1377-82. doi: 10.1056/NEJM199905063401801. N Engl J Med. 1999. PMID: 10228187 - Serum salicylate concentrations in Reye's disease. A study of 130 biopsy-proven cases.
Partin JS, Partin JC, Schubert WK, Hammond JG. Partin JS, et al. Lancet. 1982 Jan 23;1(8265):191-4. doi: 10.1016/s0140-6736(82)90759-0. Lancet. 1982. PMID: 6119559 - [Reye's syndrome--a severe complication of salicylate therapy].
Vengerovskiĭ AI, Baturina NO, Saratikov AS. Vengerovskiĭ AI, et al. Eksp Klin Farmakol. 2000 Mar-Apr;63(2):76-80. Eksp Klin Farmakol. 2000. PMID: 10834102 Review. Russian. - Reye's and Reye's-like syndromes.
Pugliese A, Beltramo T, Torre D. Pugliese A, et al. Cell Biochem Funct. 2008 Oct;26(7):741-6. doi: 10.1002/cbf.1465. Cell Biochem Funct. 2008. PMID: 18711704 Review.
Cited by
- Reye's syndrome and aspirin.
Mann RD. Mann RD. J R Coll Gen Pract. 1986 Sep;36(290):418-21. J R Coll Gen Pract. 1986. PMID: 3806491 Free PMC article. No abstract available. - Reye syndrome or side-effects of anti-emetics?
Casteels-Van Daele M. Casteels-Van Daele M. Eur J Pediatr. 1991 May;150(7):456-9. doi: 10.1007/BF01958420. Eur J Pediatr. 1991. PMID: 1655459 - Differentiation of strains of varicella-zoster virus by changes in neutral lipid metabolism in infected cells.
Jerkofsky M, De Siervo AJ. Jerkofsky M, et al. J Virol. 1986 Mar;57(3):809-15. doi: 10.1128/JVI.57.3.809-815.1986. J Virol. 1986. PMID: 3005627 Free PMC article. - Cohort-guided insights into gene-environment interactions in autism spectrum disorders.
Lipkin WI, Bresnahan M, Susser E. Lipkin WI, et al. Nat Rev Neurol. 2023 Feb;19(2):118-125. doi: 10.1038/s41582-022-00764-0. Epub 2023 Jan 16. Nat Rev Neurol. 2023. PMID: 36646930 Free PMC article. Review. - Dose-related effect of acetylsalicylic acid on replication of varicella zoster virus in vitro.
Walz-Cicconi MA, Weller TH. Walz-Cicconi MA, et al. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5223-6. doi: 10.1073/pnas.81.16.5223. Proc Natl Acad Sci U S A. 1984. PMID: 6089187 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical